365bet体育备用网址-365体育官方中文版

欢迎来到365bet体育备用网址官方网站!

365bet体育备用网址
浏览量:
产品名称:

Methoxy PEG Maleimide

产品代号:
M-MAL-20K
产品纯度:
≥ 95%
分子量:
5000 Da-20000 Da,等
产品编号:
A3115
没有此类产品
产品描述

  甲氧基聚乙二醇马来酰亚胺,亚胺产品可以抉择性的与半胱氨酸侧链上的巯基进行反应,此反应条件温和,在PH=5-6.5环境中即可进行。

  (365bet体育备用网址)提供M-MAL分子量的5000 Da,10000 Da,20000 Da,30000 Da, 40000 Da 的产品1克和10克包装。

  (365bet体育备用网址)提供分装服务,需要收取分装费用,如果您需要分装为其他规格请与我们联系。

  (365bet体育备用网址)同时提供其他分子量的M-MAL 产品,如你需要请与我司sales@jenkem.com联系。

  (365bet体育备用网址)提供大批量出产产品及GMP级别产品,如需报价请与我们联系。

References:

  1. Qi, F., at al., Conjugation of staphylokinase with the arabinogalactan-PEG conjugate: Study on the immunogenicity, in vitro bioactivity and pharmacokinetics, International Journal of Biological Macromolecules, 2019, V. 131, P. 896-904.
  2. Peng, G., et al., N-terminal site-specific PEGylation enhances the circulation half-life of Thymosin alpha 1, Journal of Drug Delivery Science and Technology, 2019, 49:405-12.
  3. Shen, L., et al., Facile synthesis of organosilica-capped mesoporous silica nanocarriers with selective redox-triggered drug release properties for safe tumor chemotherapy, Biomaterials science, 2019.
  4. Kaminskas, L.M., et al., A 30 kDa polyethylene glycol-enfuvirtide complex enhances the exposure of enfuvirtide in lymphatic viral reservoirs in rats, European Journal of Pharmaceutics and Biopharmaceutics, 2019.
  5. Lin, S.Y., et al., Multifunctional PEGylated Albumin/IR780/Iron Oxide Nanocomplexes for Cancer Photothermal Therapy and MR Imaging, Nanotheranostics, 2018, 2(2), p.106.
  6. DeGroot, A.C., et al., Entropic control of receptor recycling using engineered ligands, Biophysical journal, 2018, 114(6), p.1377-1388.
  7. Li, X., et al., Amphiphilic dendrimer engineered nanocarrier systems for co-delivery of siRNA and paclitaxel to matrix metalloproteinase-rich tumors for synergistic therapy, NPG Asia Materials, 2018, p.1.
  8. Pereira Gomes, C., et al., Fine tuning neuronal targeting of nanoparticles by adjusting the ligand grafting density and combining PEG spacers of different length, Acta Biomaterialia, 2018, V. 78, P. 247-259.
  9. Chang, X., et al., Conjugation of PEG-hexadecane markedly increases the immunogenicity of pneumococcal polysaccharide conjugate vaccine, Vaccine, 2017, 35(13):1698-704.
  10. Wan, X., et al., Effect of protein immunogenicity and PEG size and branching on the anti-PEG immune response to PEGylated proteins, Process Biochemistry, 2017, 52:183-91.
  11. Wang, Y., et al., A PEGylated bovine hemoglobin as a potent hemoglobin‐based oxygen carrier, Biotechnology progress, 2017, 33(1):252-60.
  12. Zhao, Y.Z., et al., PEGylation with the thiosuccinimido butylamine linker significantly increases the stability of haloalkane dehalogenase DhaA, Journal of Biotechnology, 2017.
  13. Xu, L., et al., Oxidized catechol-derived poly (ethylene glycol) for thiol-specific conjugation. Reactive and Functional Polymers, 2017.
  14. Zhang, C., et al., Development of long-acting ciliary neurotrophic factor by site-specific conjugation with different-sized polyethylene glycols and transferrin, International Journal of Pharmaceutics, 2017.
  15. Chen, Y., et al., Prodrug-Like, PEGylated Protein Toxin Trichosanthin for Reversal of Chemoresistance. Molecular Pharmaceutics, 2017, 14(5):1429-38.
  16. Chen, Y., et al., Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into prodrug-like feature, Biomaterials, 2017, V. 116, P. 57-68.
  17. Zhang, C., et al., Development of long-acting ciliary neurotrophic factor by site-specific conjugation with different-sized polyethylene glycols and transferrin, International Journal of Pharmaceutics, 2017, V. 529, P. 275-284.
  18. Chan, L.J., et al., Conjugation of 10 kDa linear PEG onto trastuzumab Fab’is sufficient to significantly enhance lymphatic exposure while preserving in vitro biological activity, Molecular Pharmaceutics, 2016.
  19. Sawhney, P., et al., PEGylation of Truncated Streptokinase Leads to Formulation of a Useful Drug with Ameliorated Attributes. PloS one, 2016, 11(5):e0155831.
  20. Turaga, R.C., et al., Rational design of a protein that binds integrin [alpha] v [beta] 3 outside the ligand binding site. Nature communications, 2016, 7.
  21. Gao, Y., et al., Multifunctional gold nanostar-based nanocomposite: Synthesis and application for noninvasive MR-SERS imaging-guided photothermal ablation, Biomaterials, 2015, 60: 31-41.
  22. Gupta, M.K., et al., Oligoproline-derived nanocarrier for dual stimuli-responsive gene delivery, J. Mater. Chem. B, 2015, 3, 7271-7280.
  23. Li, X., et al., D-SP5 Peptide-Modified Highly Branched Polyethylenimine for Gene Therapy of Gastric Adenocarcinoma, Bioconjugate Chemistry, 2015, 26 (8), 1494-1503.
  24. Brown, A.C., et al., Molecular interference of fibrin’s divalent polymerization mechanism enables modulation of multiscale material properties, Biomaterials, 2015, 49, P. 27-36.
  25. Wang, J., et al., Size- and surface chemistry-dependent pharmacokinetics and tumor accumulation of engineered gold nanoparticles after intravenous administration, Metallomics, 2015, 7, 516-524.
  26. Ren, H., et al., Peptide GE11–Polyethylene Glycol–Polyethylenimine for targeted gene delivery in laryngeal cancer, Medical Oncology, 2015, 32:185.
  27. Zhang, T., et al., Moderate PEGylation of the carrier protein improves the polysaccharide-specific immunogenicity of meningococcal group A polysaccharide conjugate vaccine, Vaccine, 2015, 33:28, P. 3208-3214.
  28. Hadadian, S., et al., Stability and biological activity evaluations of PEGylated human basic fibroblast growth factor, Advanced biomedical research, 2015, 4.
  29. Wang, J., et al., Retro-Inverso CendR Peptide-Mediated Polyethyleneimine for Intracranial Glioblastoma-Targeting Gene Therapy, Bioconjugate Chem., 2014, 25(2) p:414–423.
  30. Yu, W., et al., PEGylated recombinant human interferon-ω as a long-acting antiviral agent: Structure, antiviral activity and pharmacokinetics. Antiviral Research, 2014, 108: p. 142-147.
  31. Yang, Y.J., et al., Production and characterization of a fusion peptide derived from the rabies virus glycoprotein (RVG29), Protein Expression and Purification, 2014, 104, p: 7-13.
  32. Zhu, M., et al., Adsorption of polyethylene-glycolated bovine serum albumin on macroporous and polymer-grafted anion exchangers, Journal of Chromatography A, 2014, V. 1326, p. 29-38.
  33. Kharkar, P.M., et al., Dually degradable click hydrogels for controlled degradation and protein release, J. Mater. Chem. B, 2014, 2, 5511-5521.
  34. Hadadian, S., et al., Chemoselective PEGylation of cysteine analogs of human basic fibroblast growth factor (hbFGF) – design and expression, AJOL, 2014, 13:10.
  35. Yang, J., et al., Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats, European Journal of Pharmaceutical Sciences, 2014, 52:180-90.
  36. Sakoh-Nakatogawa, M., et al., Atg12–Atg5 conjugate enhances E2 activity of Atg3by rearranging its catalytic site, Nature Structural & Molecular Biology, 2013, 20, p: 433–439.
  37. Williams, C., et al, A disulphide bond in the E2 enzyme Pex4p modulates ubiquitin-conjugating activity, Scientific Reports, 2013, 3 : 2212
  38. Mu Q, et al., Molecular Insight into the Steric Shielding Effect of PEG on the Conjugated Staphylokinase: Biochemical Characterization and Molecular Dynamics Simulation, PLoS ONE, 2013, 8(7): e68559.
  39. Gao, M., et al., Development of a C-Terminal Site-Specific PEGylated Analog of GLP-1 with Improved Anti-Diabetic Effects in Diabetic Mice, Drug Development Research, 2013, 74(3): 186-193.
  40. Qian, Y., et al., PEGylated poly (2-(dimethylamino) ethyl methacrylate)/DNA polyplex micelles decorated with phage-displayed TGN peptide for brain-targeted gene delivery, Biomaterials, 2013, 34.8: 2117-2129.
  41. Gao. M., et al., PEGylation-aided refolding of globular adiponectin. World Journal of Microbiology and Biotechnology, 2013, 29(8):1525-30.
  42. Wang, J., et al., Targeted gene delivery to glioblastoma using a C-end rule RGERPPR peptide-functionalised polyethylenimine complex. International journal of pharmaceutics, 2013, 458(1):48-56.
  43. Szerencsei, R. T., et al., The topology of the C-terminal sections of the NCX1 Na+/Ca2+ exchanger and the NCKX2 Na+/Ca2+-K+ exchanger, Channels, 2013, 7.2 : 109-114.
  44. Sun, C., et al., Bifunctional PEGylated exenatide-amylinomimetic hybrids to treat metabolic disorders: an example of long-acting dual hormonal therapeutics, Journal of medicinal chemistry, 2013, 56.22 : 9328-9341.
  45. Wu, H., et al., A novel small Odorranalectin-bearing cubosomes: Preparation, brain delivery and pharmacodynamic study on amyloid-β25–35-treated rats following intranasal administration, European Journal of Pharmaceutics and Biopharmaceutics, 2012, 80(2), p: 368-378.
  46. Liu, S.. et al., Mono-PEGylation of ribonuclease A: High PEGylation efficiency by thiolation with small molecular weight reagent, Process Biochemistry, 2012, 47(9), p: 1364-1370.
  47. Tang, L., et al., Separation and detection of bis-maleimide-polyethylene glycol and mono-maleimide-polyethylene glycol by reversed-phase high pressure liquid chromatography, Journal of Chromatography A, 2012, 1246, p: 117–122.
  48. Zhan, C., et al., Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo, Journal of Controlled Release, 2012, 160:3, P. 630-636.
  49. Xin, H., et al., Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma, Biomaterials, 2011, 32(18), p: 4293-4305.
  50. Kawai, M., et al., The Heparin-binding Domain of IGFBP-2 Has Insulin-like Growth Factor Binding-independent Biologic Activity in the Growing Skeleton, The Journal of Biological Chemistry, 2011, 286, p:14670-14680.
  51. Stabenfeldt, S. E., et al., A new direction for anticoagulants: Inhibiting fibrin assembly with PEGylated fibrin knob mimics, Biotechnology and bioengineering, 2011, 108(10): 2424-2433.
  52. Rolf J. Verheul, R.J, et al., Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination, Journal of Controlled Release, 2011, V. 156:1, P. 46-52.
  53. Kaili Hu, K., et al., Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: Preparation, characterization and efficacy in Parkinson’s disease, International Journal of Pharmaceutics, 2011, 415:1–2, 30, P. 273-283.
  54. Resch, G., P. Moreillon, and V.A. Fischetti, PEGylating a bacteriophage endolysin inhibits its bactericidal activity. AMB Express, 2011, 1(29): p. 1-5.
  55. Zhan, C., et al., Cyclic RGD-poly(ethylene glycol)-polyethyleneimine is more suitable for glioblastoma targeting gene transfer in vivo, Journal of Drug Targeting, 2011, 19:7.
  56. Lamppa, J.W, et al., Genetically Engineered Alginate Lyase-PEG Conjugates Exhibit Enhanced Catalytic Function and Reduced Immunoreactivity. II RR, ed. PLoS ONE, 2011, 6(2):e17042.
  57. Barth, B.M., et al., Bioconjugation of Calcium Phosphosilicate Composite Nanoparticles for Selective Targeting of Human Breast and Pancreatic Cancers In Vivo, ACS Nano, 2010, 4(3), p. 1279–1287.
  58. Gao, M., et al., Expression, Purification, and C-terminal Site-Specific PEGylation of Cysteine-Mutated Glucagon-Like Peptide-1, Applied Biochemistry and Biotechnology, 2010, V. 162:1, p. 155-165.
  59. De Jaco, A., et al., Folding anomalies of neuroligin3 caused by a mutation in the α/β-hydrolase fold domain, Chemico-Biological Interactions, 2010, V. 187:1–3, P. 56-58.
  60. Park, J.-B., et al., PEGylation of bacterial cocaine esterase for protection against protease digestion and immunogenicity. Journal of Controlled Release, 2010, 142(2), p. 174-179.
  61. Pacchiana, G., et al., Monovalency Unleashes the Full Therapeutic Potential of the DN-30 Anti-Met Antibody, The Journal of Biological Chemistry, 2010, 285, 36149-36157.
  62. Sharma, R., et al., Bioconjugation of Calcium Phosphate Nanoparticles for Selective Targeting of Human Breast and Pancreatic Cancers In Vivo, ACS nano, 2010, 4(3):1279-1287.
未找到相应参数组,请于后台属性模板中添加
暂未实现,敬请等候
暂未实现,敬请等候
上一篇
下一篇

365bet体育备用网址|365体育官方中文版

XML 地图 | Sitemap 地图